Hitomi Sho, Koeda Yorihiko, Tosaka Kengo, Kanehama Nozomu, Niiyama Masanobu, Ishida Masaru, Itoh Tomonori, Morino Yoshihiro
Division of Cardiology, Department of Internal Medicine, Iwate Medical University, Japan.
Department of Cardiology, Japanese Red Cross Hachinohe Hospital, Japan.
Intern Med. 2024 Oct 1;63(19):2595-2603. doi: 10.2169/internalmedicine.2987-23. Epub 2024 Feb 26.
Objective This study examined variations in in-hospital mortality causes and identified independent mortality predictors among patients with acute myocardial infarction (AMI) with and without diabetes mellitus (DM). Methods We examined factors influencing in-hospital mortality in a single-center retrospective observational study. Separate multivariate analyses were conducted for both groups to identify independent predictors of in-hospital mortality. Patients This study included consecutive patients admitted to Iwate Medical University Hospital between January 2012 and December 2017 with a diagnosis of AMI. Results Of 1,140 patients meeting the AMI criteria (average age: 68.2±12.8 years old, 75% men), 408 (35.8%) had diabetes. The DM group had a 1.87-times higher 30-day mortality rate, a lower prevalence of ST-elevated MI (56.6% vs. 65.3% in non-DM, p=0.004), and more frequent non-cardiac causes of death (32% vs. 14% in non-DM, p=0.046) than the non-DM group. Independent predictors of in-hospital mortality in both groups were cardiogenic shock (CS) [DM: hazard ratio (HR) 6.59, 95% confidence interval (CI) 2.90-14.95; non-DM: HR 4.42, 95% CI 1.99-9.77] and renal dysfunction (DM: HR 5.64, 95% CI 1.59-20.04; non-DM: HR 5.92, 95% CI 1.79-19.53). Among patients with DM, a history of stroke was an additional independent predictor of in-hospital mortality (HR 2.59, 95% CI 1.07-6.31). Conclusion Notable disparities were identified in the causes of death and predictive factors of mortality between these two groups of patients with AMI. To further improve AMI outcomes, individualized management and prioritizing non-cardiac comorbidities during hospitalization may be crucial, particularly in patients with DM.
目的 本研究探讨急性心肌梗死(AMI)合并和不合并糖尿病(DM)患者住院期间死亡原因的差异,并确定独立的死亡预测因素。方法 在一项单中心回顾性观察研究中,我们研究了影响住院死亡率的因素。对两组分别进行多因素分析,以确定住院死亡率的独立预测因素。患者 本研究纳入了2012年1月至2017年12月期间在岩手医科大学医院连续入院且诊断为AMI的患者。结果 在1140例符合AMI标准的患者中(平均年龄:68.2±12.8岁,75%为男性),408例(35.8%)患有糖尿病。DM组的30天死亡率高出1.87倍,ST段抬高型心肌梗死的患病率较低(DM组为56.6%,非DM组为65.3%,p=0.004),非心脏性死亡原因更为常见(DM组为32%,非DM组为14%,p=0.046)。两组住院死亡率的独立预测因素均为心源性休克(CS)[DM组:风险比(HR)6.59,95%置信区间(CI)2.90-14.95;非DM组:HR 4.42,95%CI 1.99-9.77]和肾功能不全(DM组:HR 5.64,95%CI 1.59-20.04;非DM组:HR 5.92,95%CI 1.79-19.53)。在DM患者中,卒中史是住院死亡率的另一个独立预测因素(HR 2.59,95%CI 1.07-6.31)。结论 在这两组AMI患者中,死亡原因和死亡率预测因素存在显著差异。为进一步改善AMI的治疗效果,住院期间的个体化管理以及优先处理非心脏合并症可能至关重要,尤其是在DM患者中。